Skip to main content
. 2020 May 12;11:676. doi: 10.3389/fphar.2020.00676

Figure 4.

Figure 4

Etanercept down-regulates clinical indicators (HAQ, SJC, TJC, and DAS28) in patients with RA. (A) Change in the level of TJC scores after etanercept treatment. (B) Change in the level of SJC scores after etanercept treatment. (C) Change in the level of HAQ scores after etanercept treatment. (D) Change in the level of DAS28 scores after etanercept treatment. (E) Treatment with etanercept, the percentage of RA patients who have improved to ACR20 and ACR50 standards. *p < 0.05, **p < 0.01.